How many FDA actions has Guardian Drug Co. Inc. had?

Argus HQ has recorded 23 FDA events for Guardian Drug Co. Inc.: 0 warning letters, 23 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Guardian Drug Co. Inc.?

The most recent FDA event Argus HQ has on file for Guardian Drug Co. Inc. is dated 2026-06-10, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Guardian Drug Co. Inc. automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Guardian Drug Co. Inc. is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Guardian Drug Co. Inc.?

23 total: 0 warning letters, 23 recalls, 0 approval records, and 0 Form 483 inspection citations.

Regulatory Record: Guardian Drug Co. Inc.

FDA action counts

Total FDA actions	23
Warning letters	0
Recalls	23
Approval records	0
Form 483 inspection citations	0
Most recent action	June 10, 2026

In short: Argus HQ has recorded 23 FDA events for Guardian Drug Co. Inc.: 0 warning letters, 23 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-06-10 to 2026-06-10. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Guardian Drug Co. Inc. has 23 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Enforcement history

On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: GOODSENSE Extra Strength, Antacid TABLETS, Calcium Carbonate 750 mg, 96 Chewable… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: FAMILY WELLNESS, ULTRA STRENGT, ANTACID TABLETS, Calcium Carbonate 1000 mg, 72 C… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, D… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: KIRKLAND Signature, ULTRA STRENGTH ANTACID, Calcium Carbonate, 1000 mg, 265-coun… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: Extra strength Antacid Calcium Carbonate 750 mg, chewable tablets, 96-count bott… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: Good Neighbor Pharmacy, extra strength Antacid Calcium Carbonate 750 mg, chewabl… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: CAREone, ULTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 1000 mg, 72 chewable… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: H.E.B Extra Strength Calcium Carbonate Antacid Tablets, Calcium Carbonate 750 mg… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Guardian Drug Co. Inc., rated "high" severity in Argus HQ's classification: Guardian Drug Co. Inc. — Class II recall: CAREone, EXTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 750 mg, 96 chewable T… An FDA recall record reflects a firm removing or correcting a.

Frequently asked questions

How many FDA actions has Guardian Drug Co. Inc. had?: Argus HQ has recorded 23 FDA events for Guardian Drug Co. Inc.: 0 warning letters, 23 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
What is the most recent FDA action against Guardian Drug Co. Inc.?: The most recent FDA event Argus HQ has on file for Guardian Drug Co. Inc. is dated 2026-06-10, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for Guardian Drug Co. Inc. automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Guardian Drug Co. Inc. is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Guardian Drug Co. Inc.?: 23 total: 0 warning letters, 23 recalls, 0 approval records, and 0 Form 483 inspection citations.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Regulatory Record: Guardian Drug Co. Inc.. Digital Empire LLC. Retrieved from https://argushq.ai/company/guardian-drug-co-inc

MLA

"Regulatory Record: Guardian Drug Co. Inc.." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/guardian-drug-co-inc.

Chicago

Argus HQ Research. "Regulatory Record: Guardian Drug Co. Inc.." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/guardian-drug-co-inc.

BibTeX

@misc{argushq_argushq_ai_company_guardian_drug_co_inc_2026,
  title = {Regulatory Record: Guardian Drug Co. Inc.},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/guardian-drug-co-inc},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗